Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Société Générale M&A Activity 2020

Nov 6, 2020

1671_mrq_2020-11-06_391b28bd-ef31-420a-95f3-2ae75e3a1bfb.html

M&A Activity

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 5055E

Societe Generale SA

06 November 2020

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.       KEY INFORMATION

Name of person dealing (Note 1) Société Générale S.A.
Company dealt in Willis Towers Watson plc
Class of relevant security to which the dealings being disclosed relate (Note 2) US$0.000304635 ordinary shares
Date of dealing 05/11/2020

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Long Short
Number (%) Number (%)
(1) Relevant securities 572,050 0.44 10,024 0.01
(2) Derivatives (other than options) 858 0.00 13,183 0.01
(3) Options and agreements to purchase/sell 0 0.00 0 0.00
Total *1,731,940 *1.34 23,207 0.02

* Include the holding of 1,159,032 shares on borrow products

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1.       DEALINGS (Note 4)

(a)      Purchases and sales

Purchase/sale Number of relevant securities Price per unit USD (Note 5)
Purchase 662 186.72
Purchase 211,637 186.72
Purchase 100 186.95
Purchase 3 188.34
Purchase 3 188.34
Purchase 2 188.34
Purchase 3 188.34
Purchase 3 188.34
Purchase 2 188.34
Purchase 40 188.34
Purchase 44 188.34
Purchase 10 186.51
Purchase 7 185.91
Purchase 100 187.8
Purchase 59 185.91
Purchase 9 186.51
Purchase 81 186.51
Purchase 2 187.89
Purchase 98 187.89
Purchase 100 187.92
Purchase 86 187.8
Purchase 14 187.8
Purchase 100 185.7
Sale 52 186.09
Sale 21 187.39
Sale 2 187.5
Sale 30 187.39
Sale 36 187.28
Sale 20 187.5
Sale 100 187.28
Sale 21 186.51
Sale 15 185.88
Sale 52 186.79
Sale 48 186.79
Sale 48 186.09
Sale 12 185.98
Sale 22 186.84
Sale 54 185.63
Sale 21 187.3
Sale 100 186.91
Sale 85 188.68
Sale 7 188.68
Sale 9 189.02
Sale 40 189.02
Sale 51 189.02
Sale 88 187.82
Sale 12 187.82
Sale 100 189.12
Sale 1 188.68
Sale 7 188.68
Sale 147 186.72
Sale 18 189.268
Sale 3 189.268
Sale 100 186.64
Sale 9 187.67
Sale 1 187.8
Sale 3 187.8
Sale 4 187.8
Sale 1 187.69
Sale 12 187.81
Sale 9 187.64
Sale 12 187.71
Sale 1 187.8
Sale 10 187.8
Sale 1 187.64
Sale 2 187.71
Sale 2 187.64
Sale 3 186.22
Sale 1,540 186.72
Sale 770 186.72
Sale 1,155 186.72
Sale 385 186.72
Total Purchases 213,165
Total Sales 5,242

(b)      Derivatives transactions (other than options transactions)

Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit USD

(Note 5)

(c)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii)      Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2.       OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any

other person relating to the voting rights of any relevant securities under any option referred to on this

form or relating to the voting rights or future acquisition or disposal of any relevant securities to which 

any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            No

Date of disclosure 06/11/2020
Contact name Société Générale - Disclosure team
Telephone number +33 1 42 14 92 74
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEFIFETLALRIII